Given the global rise of AD within aging populations and the therapeutic importance of AChE inhibitors for treatment, a detailed understanding of the electronic structure and molecular parameters for enzyme-inhibitor molecular contacts of 1 may advance design principles for new AD therapeutics. The gene discussed is ACHE; the disease is Alzheimer disease.